The role of oxidative stress in the pathogenesis of diabetic nephropathy.

被引：0
|
作者：
Ahn, C
Lee, G
Ha, H
Cha, B
Song, Y
Lim, S
Kim, K
Lee, H
Huh, K
机构：
[1] Yonsei Univ, Coll Med, Youngdong Severance Hosp, Seoul 120749, South Korea
[2] Soon Chun Hyang Univ, Hyonam Kidney Lab, Seoul, South Korea
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1099
引用
收藏
页码：A355 / A355
页数：1
相关论文
共 50 条
  • [1] Role of methylglyoxal in the pathogenesis of diabetic nephropathy.
    Chuang, P
    Saleem, MA
    Mathieson, PW
    Hudson, BG
    Voziyan, PA
    JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (01) : S312 - S312
  • [2] Role of amylin in the pathogenesis of diabetic nephropathy.
    Liu, ZH
    Peng, A
    Zhou, H
    Li, LS
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 649A - 649A
  • [3] Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C
    Ha, H
    Kim, KH
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1999, 45 (2-3) : 147 - 151
  • [4] Diabetic nephropathy. New aspects of pathogenesis
    Rüster C.
    Wolf G.
    Der Nephrologe, 2011, 6 (5): : 390 - 399
  • [5] Diabetic nephropathy: Is there a role for oxidative stress?
    Sagoo, Manpreet K.
    Gnudi, Luigi
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 116 : 50 - 63
  • [6] Role of oxidative stress in diabetic nephropathy
    Vasavada, N
    Agarwal, R
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2005, 12 (02) : 146 - 154
  • [7] ROLE OF OXIDATIVE STRESS IN THE DEVELOPMENT OF DIABETIC NEPHROPATHY
    HA, H
    KIM, KH
    KIDNEY INTERNATIONAL, 1995, 48 : S18 - S21
  • [8] Involvement of heparanase in the pathogenesis and early diagnosis of diabetic nephropathy.
    Katz, A
    VanDyk, D
    Eingorn, E
    Erman, A
    Darmon, D
    Horovitz, H
    Vlodavsky, I
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0571 - A0571
  • [9] Oxidative Stress: Meeting Multiple Targets in Pathogenesis of Diabetic Nephropathy
    Arora, Mandeep Kumar
    Singh, Umesh Kumar
    CURRENT DRUG TARGETS, 2014, 15 (05) : 531 - 538
  • [10] Diabetic nephropathy.
    Hasslacher, C.
    Wolf, G.
    Kempe, P.
    Ritz, E.
    DIABETOLOGIE UND STOFFWECHSEL, 2010, 5 : S113 - S116
12345